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Abstract
Mast cell numbers and allergen specific IgE are increased in the lungs of patients with allergic asthma and this can be
reproduced in mouse models. The increased number of mast cells is likely due to recruitment of mast cell progenitors that
mature in situ. We hypothesized that formation of IgE immune complexes in the lungs of sensitized mice increase the
migration of mast cell progenitors to this organ. To study this, a model of allergic airway inflammation where mice were
immunized with ovalbumin (OVA) in alum twice followed by three daily intranasal challenges of either OVA coupled to
trinitrophenyl (TNP) alone or as immune complexes with IgE-anti-TNP, was used. Mast cell progenitors were quantified by a
limiting dilution assay. IgE immune complex challenge of sensitized mice elicited three times more mast cell progenitors per
lung than challenge with the same dose of antigen alone. This dose of antigen challenge alone did not increase the levels of
mast cell progenitors compared to unchallenged mice. IgE immune complex challenge of sensitized mice also enhanced the
frequency of mast cell progenitors per 10
6 mononuclear cells by 2.1-fold. The enhancement of lung mast cell progenitors by
IgE immune complex challenge was lost in FcRc deficient mice but not in CD23 deficient mice. Our data show that IgE
immune complex challenge enhances the number of mast cell progenitors in the lung through activation of an Fc receptor
associated with the FcRc chain. This most likely takes place via activation of FceRI, although activation via FccRIV or a
combination of the two receptors cannot be excluded. IgE immune complex-mediated enhancement of lung MCp numbers
is a new reason to target IgE in therapies against allergic asthma.
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Introduction
The lungs from patients with allergic asthma and mice with
antigen-induced allergic lung inflammation share several common
features such as increased numbers of Th2-cells, eosinophils and
mast cells as well as increased levels of antigen-specific IgE [1,2,3].
Mast cells originate from bone marrow derived mast cell
progenitors (MCp) that upon entry to the peripheral organs
mature into mast cells [4]. Naı ¨ve mice and mice sensitized with
intraperitoneal injection of antigen have few MCp in their lungs,
but antigen aerosol challenge induces MCp recruitment and
increases both frequency and the total number of MCp per lung
[5]. For recruitment to occur, the MCp need to migrate from the
blood vessels through the lung endothelium. This process is
dependent on expression of a4-integrins on the MCp interacting
with endothelial VCAM-1 [5]. In addition, although MCp
recruitment is regulated by CXCR2 and CCL2/CCR2, the
chemokine receptors need to be expressed by the lung stroma cells
rather than on the MCp for optimal recruitment to lung [3,6].
Furthermore, MCp recruitment is regulated by IL-9, most likely
produced by NKT-cells [7].
The importance of allergen-specific IgE production in allergic
asthma has been widely appreciated through the recent success with
the anti-IgE monoclonal antibody, omalizumab [8]. This antibody
targets the Fc-binding part of IgE thereby hindering the binding of
IgE and IgE immune complexes to IgE-receptors and leads to an
attenuation of asthma exacerbations and symptoms. Further,
genetic analyses reveal an association between IgE levels and
asthmaseverity[9,10]. Studies inmicehaveshown thatIgEand IgE
immune complexes can bind to several activating receptors. Most
well known is the high affinity receptor for IgE, FceRI, expressed
mainly on mast cells and basophils. Besides activating mast cells and
basophils leading to degranulation and release of proinflammatory
mediators, IgE also functions as a survival factor for these cells [11].
FccRIII is another receptor that bind IgE immune complexes of
certain allotypes with low affinity [12]. A more recently described
receptor that binds IgE immune complexes is FccRIV, found on
macrophages, dendritic cells and polymorphonuclear cells [13,14].
Like FccRIII and FceRI, FccRIV is dependent on the common
FcRc-chain for signaling and is thought to synergize with FceRI in
the lung to mediate the IgE immune complex induced infiltration of
Mac1
+ Gr1
+ polymorphonuclear cells seen in bronchoalveolar
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CD23, a C-type lectin expressed by B-cells and follicular dendritic
cells. This receptor is required for the IgE-mediated enhancement
of antibody and CD4
+ T-cell responses seen after primary
intravenous immunizations [15], but is also thought to negatively
regulate the immune response [16]. Thus, there are several
receptors that IgE immune complexes could utilize to stimulate
the immune response.
Because enhanced antigen specific IgE and enhanced numbers
of lung mast cells is a shared phenomenon in human asthma and
in mouse models for this disease, we hypothesized that formation
of IgE immune complexes locally in the lung enhances migration
of MCp into the lung. To test this, OVA sensitized mice were
given an intranasal challenge with either OVA-TNP alone or
together with IgE-anti-TNP as an immune complex. Using a
model of allergic airway inflammation, we demonstrate for the first
time that IgE immune complex challenge stimulated MCp
recruitment to the lung when compared to challenge with same
dose antigen alone. The IgE immune complex stimulated MCp
recruitment was dependent on the engagement of an Fc receptor
that use the common FcRc chain for signaling, most likely FceRI.
Materials and Methods
Ethics statement
All animal experiments were approved by Uppsala animal
research ethics committee (protocol number C116/7 and C3/10).
The mice were bred and maintained in the animal facilities at the
National Veterinary Institute (Uppsala, Sweden). Skilled personnel
under the supervision of the veterinarian in charge routinely
observed the health status of the mice.
Animals
6–14 week old male BALB/c, CD23
2/2 [17] backcrossed to
BALB/c for 10 generations, and FcRc
2/2 [18] backcrossed to
BALB/c for 12 generations were used.
Reagents
OVA grade V purchased from Sigma-Aldrich (St Louis, MO,
USA) was used for sensitization and for coupling to TNP
(picrylsulfonic acid/hydrate) (Sigma-Aldrich). TNP was coupled
to OVA in 0.28 M cacodylate buffer, pH 6.9 at room tempera-
ture. After 80 min incubation, the reaction was stopped by adding
excess of glycyl-glycine (1 mg/ml; Merck, Darmstadt, Germany).
The formed OVA-TNP was dialyzed against PBS, sterile filtered
and kept at +4uC. The number of TNP residues per OVA was
obtained by measuring the absorbance at 280 nm and 340 nm, in
accordance with [19]. A ratio of 2.3 TNP:OVA was used.
Monoclonal IgE-anti-TNP was obtained from the IGELb4
hybridoma producing murine IgE-anti-TNP [20]. IGELb4 were
cultured in DMEM supplemented with 5% heat-inactivated FCS,
10 mM HEPES, 100 U/ml penicillin, 100 mg/ml streptomycin,
2 mM L-glutamine, 1 mM sodium pyruvate, 50 mM 2-mercapto
ethanol (all from Sigma-Aldrich). IgE was purified by affinity
chromatography on a Sepharose column conjugated with
monoclonal rat anti-mouse kappa (187.1.10) and eluted with
0.1 M glycine-HCl buffer, pH 2.8 [21]. The solution was dialyzed
to PBS, sterile filtered, quantified by reading the absorbance at
280 nm assuming that an absorbance of 1.5 equals 1 mg/ml IgE
and stored at 220uC.
OVA sensitization and challenge protocol
Mice were sensitized on day 0 and day 7 with 10 mg OVA grade
V (Sigma-Aldrich) adsorbed to 1 mg alum (Pierce, Thermo
Scientific, Rockford, USA) in 200 ml sterile PBS. Day 17–19 mice
were anesthesized with 50 ml solution consisting of Hypnorm
(Vetapharma Ltd, Leeds, UK) and Dormicum (Roche, Basel,
Switzerland) given subcutaneously. This solution was prepared by
diluting Hypnorm 1:1 with sterile water and Dormicum 1:1 with
sterile water separately and then mixing them together (1:1).
Anesthesized mice were given daily intranasal doses with either
70 mg OVA-TNP alone in sterile PBS or together with 70 mgI g E -
anti-TNP (Figure 1). Both solutions were prepared in a total volume
of 30 ml. In some experiments OVA sensitized mice were instead
challenged with 1% OVA in PBS as aerosol using a PARI nebulizer
(Starnberg, Germany) for 30 min daily during day 17–19.
Preparation of mononuclear cells and mast cell
progenitor quantification
On day 20, mice were killed by an overdose of isoflurane
(Schering Plough A/S, Farum, Denmark) and the lungs were
perfused with 10 ml of sterile PBS administered via the right
ventricle. Lungs and spleens were harvested into ,10 ml of
complete RPMI (RPMI 1640 containing 100 U/ml penicillin,
100 mg/ml streptomycin, 10 mg/ml gentamicin, 2 mM L-gluta-
mine, 10 mM HEPES, 0.1 mM non-essential amino acids, 1 mM
sodium pyruvate, 50 mM 2-mercaptoethanol and 10% heat-
inactivated FCS (all from Sigma-Aldrich)). In one experiment,
the mice were anesthetized and bronchoalveolar lavage was
performed by flushing the lungs twice with 0.5 ml PBS.
The obtained lungs were finely chopped with scalpels and
transferred to 50 ml plastic tubes with 10 ml of complete RPMI
1640 plus 1 ml of ,1830 units of collagenase type IV (Gibco,
Paisley, Scotland, UK or Worthington, Lakewood, NJ, USA). The
lung homogenates were incubated for ,20 min at 37uC. The
released cells were harvested whereas the undigested tissue pieces
were subjected to another enzymatic digestion (for a total of three
digestions). The cells from the three digestions were pelleted,
resuspended in 44% Percoll (Sigma-Aldrich) and underlayed with
a 67% Percoll layer. After spinning at 4006g for 20 min at 4uC,
lung mononuclear cells (MNC) were harvested from the 44/67%
Percoll interface. The MNC obtained from two Percoll gradients
per mouse lung were pooled and washed in complete RPMI 1640.
The total number of viable MNC was determined by trypan blue
dye exclusion on a hemacytometer. The cells were serially 2-fold
diluted to eight concentrations beginning at 20,000 cells/well in
complete RPMI and 100 ml of each dilution was added to eight
wells of two sterile 96-well flat-bottomed tissue culture plates per
mouse lung. Thereafter, each well received 100 ml of gamma-
irradiated (30 Gy) splenic feeder cells plus IL-3 (40 ng/ml) and
Figure 1. An outline of the experimental protocol. All mice were
sensitized day 0 and day 7 with i.p. injections of 10 mg OVA adsorbed to
1 mg alum. Day 17–19 the mice were challenged intranasally (i.n.) with
either 70 mg OVA-TNP alone or together with 70 mg IgE-anti-TNP. Mice
were analyzed 24 h after challenge (see materials and methods).
doi:10.1371/journal.pone.0020261.g001
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the X-63 B-cell line [22] and quantified by ELISA. Recombinant
SCF was purchased from Peprotech (#250-03, Rocky Hill, NJ,
USA). After 10–12 days of incubation in humidified 37uC
incubators with 5% CO2, wells containing mast cell colonies were
counted with an inverted microscope. After culture, only mast cell
colonies appeared in the plates. They were distinguished from the
feeder matrix as small-medium sized round cells in large colonies
[5,23,24]. The total number of lung MCp/mouse was derived by
multiplying the concentration of MCp (MCp/10
6 MNC) by the
total number of MNC obtained from each mouse lung.
Flow cytometry
Lung MNC or cells from bronchoalveolar lavage were washed in
FACS buffer (2% FCS in PBS pH 7.4) and fluorescence staining
was performed at 4uC in 100 ml FACS buffer for 30 min. After pre-
incubation with Fc-block (2.4G2, BD Bioscience, Franklin Lakes,
NJ, USA), the following antibodies were used to detect CD3
+ and
CD3
+/CD4
+ T cells and CD19
+ B cells: Alexa 488 conjugated
hamster anti-mouse CD3 (500-A2, Caltag Laboratories, Caltag-
Medsystems Ltd, Buckingham, UK), PE conjugated rat anti-mouse
CD4 (L3T4, BD Bioscience) and FITC conjugated rat anti-mouse
CD19 (1D3, BD Bioscience). Dendritic cells were identified as
CD11c
+, MHC-II
hicells using APCconjugated hamster anti-mouse
CD11c(HL3,BDBioscience) andPEconjugated mouseanti-mouse
I-A
d (AMS-32.1, BD Bioscience). PE-Cy7 conjugated hamster anti-
mouse CD11c (N418, eBioscience, Hatfield,UK), FITC conjugated
rat anti-mouse CD45 (30-F11, BD Bioscience) and PE conjugated
rat anti-mouse SiglecF (E50-2440, BD Bioscience) along with
matched isotype controls were used to detect eosinophils in
bronchoalveolar lavage. Cells were analyzed using a FACScan or
a LSRII (BD Bioscience) cytometer and analyzed using the FlowJo
software (Tree Star Inc, Ashland, OR, USA).
Statistics
As the method used for quantifying lung MCp is very time
consuming we were unable to perform individual experiments with
enough animals in each group to obtain statistics. Thus, the values
obtained from analyses of each individual mouse in all experiments
were used and the groups were compared using a two-way
ANOVA. Before the analysis the values were transformed to a
Gaussian distribution by calculating the natural logarithm of each
value. The p value for the interaction term was greater than 0.05 in
all analyses. Differences were considered statistically significant if
p,0.05. Eosinophils were quantified in one experiment and these
groups were compared using an unpaired Student’s t-test. The
statistics were calculated using GraphPad Prism 5.0b.
Results
IgE immune complex challenge enhance the lung mast
cell progenitor number compared to the same dose
antigen alone
Previously, the same sensitization protocol as in the present
investigation was used in studies of antigen-induced MCp
recruitment to lung, but the mice were challenged with 1%
OVA-aerosol (8 ml of 10 mg/ml) for 30 min a day [5] instead of
70 mg OVA-TNP intranasally. To establish how efficient 70 mg
OVA-TNP administered intranasally is to induce higher numbers
of lung MCp as compared to only sensitized (not challenged) or
OVA aerosol challenged mice, we analyzed the lung MCp in these
groups (Figure 2). As expected from earlier studies, sensitized mice
challenged with 1% OVA aerosol had high numbers of lung MCp,
26876826 MCp/lung (Figure 2A) and 409676 MCp/10
6 MNC
(Figure 2C). OVA sensitization and aerosol challenge thus induced
a 10-fold increase in total lung MCp and a 5-fold increase in MCp
frequency in the lungs as compared to sensitized mice challenged
intranasally with OVA-TNP and unchallenged mice (p,0.05). In
contrast, sensitized mice challenged with OVA-TNP alone had the
same frequency and total amount of lung MCp as sensitized mice
left unchallenged (Figure 2D). As described previously, OVA
sensitized and naı ¨ve mice have similar low basal homing of MCp
to lung [5,25]. Thus, 70 mg OVA-TNP alone is unable to induce
an enhancement of lung MCp over the basal homing.
To study the effects of IgE immune complexes on the number of
MCp in the lung, OVA sensitized BALB/c mice were challenged
witheitherOVA-TNPaloneorIgE-anti-TNP/OVA-TNPimmune
complexes intranasally during three consecutive days. The numbers
of MCp as well as MNC in the two groups were compared. One
representative out of the nine independent experiments performed
is shown in Figure 3A–C. Here, sensitized mice given OVA-TNP
challenge alone had 3276185 MCp per lung whereas IgE-anti-
TNP/OVA-TNP challenge enhanced the number of MCp 3.2-fold
to 10466317 MCp per lung (Figure 3A). IgE alone did not enhance
the MCp numbers in the lung (Figure 3A). Looking at all nine
experiments, 3.0 times more lung MCp were elicited in sensitized
IgE-anti-TNP/OVA-TNP challenged mice compared to OVA-
TNP challenged animals (p,0.001, Figure 3D left column). We
noted a small enhancement (1.4-fold) in the number of MNC in
IgE-anti-TNP/OVA-TNP challenged compared to OVA-TNP
challenged mice (Figure 3B, D), suggesting that other cell
populations were also influenced. However, the specific increase
in MCp/10
6 MNC was 2.1 times higher in sensitized mice
challenged with IgE-anti-TNP/OVA-TNP than in mice challenged
with OVA-TNP (Figure 3C, D). Thus, IgE-anti-TNP/OVA-TNP
immune complexes do not just increase the number of MNC, but
stimulate an increase in lung MCp specifically.
Effects of IgE immune complex challenge on other cell
populations in the lungs
Since the MNC numbers were increased, albeit only 1.4-fold, in
sensitized mice challenged with IgE-anti-TNP/OVA-TNP, flow
cytometry analyses of the residual MNC left after setting up the
assay to quantify MCp was performed. We analyzed the
percentage and total number of B-cells (CD19
+), T-cells (both
CD3
+ and CD3
+/CD4
+) as well as dendritic cells (CD11c
+,
MHCII
hi). As shown in Figure 3E, there was an increase in the
total number, but not in the frequency, of B-lymphocytes and a
tendency towards an increased total number of CD3
+ T-cells.
There was also a tendency towards increased total numbers of
CD4
+ T-helper cells (results not shown). Dendritic cells were
analyzed in three experiments but we could not detect any
differences between the treatment groups (Figure 3E).
Since a paper by Zuberi et al [26] demonstrated using a similar
protocol that eosinophil numbers were increased in bronchoalveolar
lavage fluid in sensitized mice challenged with IgE immune
complexes, one experiment where bronchoalveolar lavage was
analyzed for eosinophils (CD11c
2,C D 4 5
+,S i g l e c -F
+)w a s
performed. Sensitized and IgE-anti-TNP/OVA-TNP challenged
mice had 3766% eosinophils and 37957610343 in total whereas
sensitized mice given the same dose OVA-TNP alone had less
eosinophils(1767%, p=0.07;707863891 in total number,p,0.05).
CD23 deficient mice have normal number of lung mast
cell progenitors after IgE immune complex challenge
CD23 is one candidate receptor for mediating biological effects
of IgE immune complexes. However, OVA sensitized and IgE-
IgE-IC Increase Lung Mast Cell Progenitors
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2/2 and wild type mice
had similar numbers of MCp in their lungs (CD23
2/2: 10026359
MCp per lung versus WT: 9446493) (Figure 4A). Further, there
were no differences in the frequency of MCp/10
6 MNC
(Figure 4B) and both strains had similar MNC yields (results not
shown). Altogether, four experiments comparing IgE-anti-TNP/
OVA-TNP challenge of OVA sensitized CD23
2/2 and BALB/c
mice resulted in stimulation indices close to 1 (Figure 4C). Thus,
the stimulating effect of IgE immune complexes on lung MCp
numbers is not mediated by CD23.
IgE immune complex-induced enhancement of lung
mast cell progenitors is lost in FcRc deficient mice
The common Fc-receptor c chain (FcRc) is required for
signaling by FceRI, FccRI, FccRIII and FccRIV [13,18]. All of
these except FccRI can bind IgE as an immune complex [14], and
we wanted to find out if the enhancement of lung MCp seen after
IgE immune complex challenge was dependent on a FcRc-
associated receptor. To this end, wild type and FcRc
2/2 mice
were OVA sensitized and challenged with IgE-anti-TNP/OVA-
TNP. The number of MCp/lung in FccR
2/2 mice was less than
half of that in wild type mice (e. g. 368689 versus 8936306,
Figure 5A). The lung MCp frequency was also reduced in
sensitized IgE-anti-TNP/OVA-TNP challenged FccR deficient
mice compared to wild type mice (Figure 5B). In summary, there
was 2.4 times more MCp/lung (p,0.01) and 1.8 times more
MCp/10
6 MNC (p,0.05) in IgE-anti-TNP/OVA-TNP chal-
lenged wild type than in FcRc
2/2 mice (Figure 5C). These
findings implied that IgE-anti-TNP/OVA-TNP could not en-
hance MCp recruitment in FcRc
2/2 mice. However, the low
response to IgE immune complexes in FcRc
2/2 mice does not per
se prove that IgE cannot enhance the number of lung MCp in
FcRc
2/2 mice. A possibility is that FcRc
2/2 mice challenged
with OVA-TNP alone have an even lower level of lung MCp and
that the levels seen in IgE-anti-TNP/OVA-TNP challenged
FcRc
2/2 mice are nevertheless enhanced. Therefore, sensitized
FcRc
2/2 mice were challenged with IgE-anti-TNP/OVA-TNP
or OVA-TNP alone. Both groups had similar frequency and total
numbers of MCp (Figure 6). Thus, IgE immune complexes did not
enhance lung MCp in FccR
2/2 mice. Altogether, our observa-
tions suggest that the enhancement of lung MCp caused by IgE
immune complexes is mediated by an FcRc-associated receptor.
Figure 2. Intranasal challenge with OVA-TNP does not enhance the lung MCp number over basal levels. (A–C) One experiment showing
the quantification of MCp and MNC from wild type (WT) mice sensitized with OVA/alum and challenged with either OVA-TNP alone, OVA aerosol or
left unchallenged. The error bars shown are SEM. (D) A comparison of the OVA-TNP challenged and the unchallenged group from the two
experiments performed expressed as a stimulation index (S.I.) where the numbers represent the mean number of MCp/lung, MNC/lung or MCp/10
6
MNC per experiment of sensitized mice challenged with OVA-TNP divided by the mean number obtained from sensitized mice left unchallenged. The
mean of the S.I. from the experiments is given in bold text at the bottom. The experiment shown in (A–C) is indicated in bold italics. There was no
statistical difference (ns) between the OVA-TNP challenged and the unchallenged mice in the tested parameters using a two-way ANOVA from a
comparison of all individual mice from each group from the two experiments.
doi:10.1371/journal.pone.0020261.g002
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Germinal center formation and production of allergen specific
IgE locally in the lung takes place after airway challenge [27]
together with the appearance of increased numbers of mature
mast cells [1,2]. Previous studies show that the mechanisms that
govern the low basal homing of MCp and the antigen-induced
recruitment of MCp to lung differ and suggest that the mast cell
Figure 3. Challenge with IgE immune complex enhance lung MCp numbers compared to antigen alone. (A–C) A representative
experiment showing the quantification of MCp and MNC from wild type (WT) mice sensitized with OVA/alum and challenged with OVA-TNP, IgE-anti-
TNP/OVA-TNP or IgE-anti-TNP alone. The error bars shown are SEM. (D) A summary of all nine experiments performed expressed as a stimulation
index (S.I.) where the numbers represent the mean number of MCp/lung, MNC/lung or MCp/10
6 MNC per experiment of sensitized mice challenged
with IgE-anti-TNP/OVA-TNP divided by the mean number obtained from sensitized mice challenged with OVA-TNP alone for each experiment. (E) A
summary of all the experiments where B-cells, T-cells and dendritic cells (DC) were analyzed with flow cytometry. In some experiments flow cytometry
was not done (nd). The mean of the S.I. from all experiments is given in bold text at the bottom. The experiment shown in (A–C) is indicated in bold
italics. The p-values shown are derived from two-way ANOVA from a comparison of all individual mice in each group from the nine experiments.
doi:10.1371/journal.pone.0020261.g003
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hypothesized that formation of IgE immune complexes locally in
the lung enhances the MCp recruitment. To test this, IgE immune
complexes or antigen alone were administered intranasally to
antigen-sensitized mice (Figure 1). Despite the low influx of MCp
with intranasal challenge of antigen alone, the same low dose of
antigen in complex with IgE stimulated the increase of three times
more MCp per mouse lung (Figure 3A, D). This effect was neither
due to differences in the levels of endogenously produced antigen-
specific IgE (OVA-specific IgE levels in serum were similar
between the groups, results not shown) nor to impurities in the
antibody preparation, as challenge with anti-TNP IgE alone did
not enhance the number of lung MCp (Figure 3A, C). OVA-TNP
(70 mg) in itself does not induce higher number of lung MCp over
the basal homing seen in naı ¨ve or only sensitized mice (Figure 2A–
D, [5,25]). Therefore it is remarkable that specific IgE together
with this suboptimal antigen dose is able to induce a 2.1-fold
increase in MCp/10
6 MNC and a 3-fold increase in total MCp
content (Figure 3D). Although we do not provide experimental
evidence for that the increase in lung MCp is due to recruitment as
opposed to increased proliferation of lung MCp in situ, we favor
Figure 4. IgE immune complex challenge induces similar lung
MCp levels in CD23
2/2 as in wild type. (A–B) A representative
experiment showing the quantification of MCp from wild type (WT) or
CD23
2/2 mice sensitized with OVA/alum and challenged with IgE-anti-
TNP/OVA-TNP. The error bars shown are SEM. (C) A summary of all the
four experiments performed expressed as a stimulation index (S.I.)
where the numbers represent the mean number of MCp/lung or MCp/
10
6MNC per experiment of sensitized WT mice challenged with IgE-anti-
TNP/OVA-TNP divided by the mean number obtained from CD23
2/2
mice treated in parallel. The mean of the S.I. from all experiments is
given in bold text at the bottom. The representative experiment shown
in (A–B) is indicated in bold italics. There was no statistical difference
(ns) in the tested parameters using a two-way ANOVA from a
comparison of all individual mice from each group from the four
experiments.
doi:10.1371/journal.pone.0020261.g004
Figure 5. FcRc-chain deficient mice have a reduced number of
lung MCp after IgE immune complex challenge. (A–B) A
representative experiment showing the quantification of MCp from
wild type (WT) or FcRc
2/2 sensitized with OVA/alum and challenged
with IgE-anti-TNP/OVA-TNP (C) A summary of all the four experiments
performed expressed as a stimulation index (S.I.) where the numbers
represent the mean number of MCp/lung or MCp/10
6 MNC of sensitized
WT mice challenged with IgE-anti-TNP/OVA-TNP divided by the mean
number obtained in FcRc
2/2 mice treated in parallel. The mean of the
S.I. from all experiments is given in bold text at the bottom. The
representative experiment shown in (A–B) is indicated in bold italics.
The p-values shown are derived using a two-way ANOVA from a
comparison of all individual mice from each group from the four
experiments.
doi:10.1371/journal.pone.0020261.g005
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because of the limited time (three days) of treatment with IgE
immune complexes. Moreover, mice challenged with IgE immune
complexes and IgE alone have encountered the same total amount
of IgE. Nevertheless, IgE immune complex challenge stimulated 3-
fold more lung MCp whereas IgE alone failed to increase lung
MCp (Figure 3A–C). Therefore at least increased proliferation of
MCp mediated by IgE is unlikely. Since mature mast cells are
excluded from the MNC preparation we can exclude that the
increase of lung MCp are due to proliferation of lung mast cells.
Recently, Mathias et al found that wild type mice had higher
number of mature mast cells in trachea, bronchus and spleen than
IgE deficient mice after three weeks of Aspergillus treatments [28].
Despite the lack of IgE, the increased level of lung MCp was intact
in the IgE deficient mice after three weeks of challenge. The
increase in airway mast cells in wild types was interpreted as IgE-
mediated enhancement of mast cell survival through FceRI.
Presuming that this protocol induced high levels of antigen-specific
IgE locally in the lungs leading to formation of IgE immune
complexes in the wild type mice, IgE immune complex mediated
enhancement of MCp recruitment could have taken place earlier
as IgE levels rise already after seven days. It is also possible that the
IgE immune complex enhancement of MCp recruitment only
occurs at lower antigen doses.
IgE-mediated immune reactions are both positively and
negatively regulated by the low-affinity receptor for IgE, CD23
[16,29]. Administration of small protein antigens in complex with
specific IgE enhances the antibody responses by a 100-fold and T-
cell proliferation by 10-fold as compared to administration of
antigen alone [17,21,30]. These effects are seen only at low doses
of antigen and are completely dependent on CD23, and it
therefore seemed possible that the enhanced recruitment of MCp
could also be mediated by CD23. However, sensitized and IgE
immune complex challenged CD23
2/2 mice had similar lung
MCp numbers as wild type mice treated in parallel, thus excluding
a major involvement of this receptor (Figure 4).
Other known IgE-binding receptors are FceRI, FccRII,
FccRIII, and FccRIV [13,18]. Of these, all except FccRII use
the common FcRc chain for signaling [18]. The number and
frequency of lung MCp in sensitized, IgE immune complex
challenged FcRc
2/2 mice was significantly reduced as compared
to that in wild type mice (Figure 5). This finding was further
corroborated by the fact that antigen specific IgE did not enhance
the lung MCp content in FcRc
2/2 mice: similar numbers of MCp
were found in FcRc
2/2 mice challenged with IgE immune
complexes as in FcRc
2/2 mice challenged with antigen alone
(Figure 6). Thus, our results suggest that the enhanced level of lung
MCp after challenge with IgE immune complexes is dependent on
an FcRc-chain-associated receptor, i.e. FceRI, FccRIII, or
FccRIV. IgE immune complexes of allotype a, and possibly
allotype e, bind FccRIII [12,14,31] whereas IgE immune
complexes of allotype b (which is used in our study) do not bind
to this receptor [14]. Therefore, it is unlikely that FccRIII is
involved in MCp recruitment, and only FceRI and FccRIV
remain as candidate receptors.
FccRIV is a recently discovered Fc-receptor for IgG [13,14],
which also has intermediate affinity for IgE immune complexes
(Ka>1.4–7.5610
5 M
21 depending on the study and the source of
IgE). Since an FccRIV knockout mouse strain is not available,
conclusions about the in vivo role of IgE binding to this receptor
was based on comparisons between FcRc
2/2 mice and quintuple
knockout mice lacking FccRI/II/III, FceRI, and CD23. The
authors concluded that IgE immune complex-induced infiltration
of polymorphonuclear cells to the lung was caused by alveolar
macrophages expressing FccRIV in synergy with lung mast cells
expressing FceRI [14]. This effect was only seen after pre-
treatment with supernatants from activated mast cells. Since mast
cells do not express FccRIV [13], this may suggest that FceRI has
a superior biological role over FccRIV to mediate IgE immune
complex effects.
FceRI binds IgE immune complexes with high affinity
(Ka>10
9–10
10 M
21) [14,29,32] and thus has 1000–70 000-fold
higher affinity for IgE immune complexes than FccRIV. For this
reason, FceRI is more likely to be involved in IgE immune
Figure 6. IgE immune complex-induced enhancement of lung
MCp is dependent on an FcRc chain associated receptor. (A–B) A
representative experiment showing the quantification of MCp from or
FcRc
2/2 sensitized with OVA/alum and challenged with either IgE-anti-
TNP/OVA-TNP or OVA-TNP alone (C) A summary of all the three
experiments performed expressed as a stimulation index (S.I.) where the
numbers represent the mean number of MCp/lung or MCp/10
6MNC of
sensitized FcRc
2/2 mice challenged with IgE-anti-TNP/OVA-TNP divided
by the mean number obtained in FcRc
2/2 mice challenged with OVA-
TNP alone. The mean of the S.I. from all experiments is given in bold
text at the bottom. The representative experiment shown in (A–B) is
indicated in bold italics. There was no statistical difference (ns) in the
tested parameters using a two-way ANOVA from a comparison of all
individual mice from each group from the three experiments.
doi:10.1371/journal.pone.0020261.g006
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FccRIV. Indirect support for FceRI also comes from comparisons
between our finding on eosinophils in bronchoalveolar lavage
(described below) and a study by Zuberi et al. They showed that
bronchoalveolar lavage from mice challenged with in vitro formed
IgE-complexes had higher levels of IL-4 and more eosinophilia
than mice challenged with antigen alone and that the effect was
dependent on FceRI [26]. As eosinophils are excluded from the
lung MNC preparations, eosinophils were generally not studied in
our experiments. However, in one experiment bronchoalveolar
lavage was analyzed as described in the results and similar to
Zuberi and colleagues, we found that sensitized mice challenged
with IgE immune complex had more eosinophilia than mice
challenged with antigen alone. This analogy is compatible with the
idea that FceRI is the receptor mediating the enhancement of the
number of lung MCp by IgE immune complexes in our system.
Altogether, the ability of IgE immune complexes to enhance the
number of MCp in the lung is a new way for IgE to influence mast
cells and thereby the allergic response. The results suggest that
formation of IgE immune complexes locally in the lung enhances
the lung MCp number through an FcRc associated receptor. The
effect is most likely mediated via activation of mast cells and
basophils through FceRI, although a combined effect of IgE
immune complexes binding to FccRIV on other lung cells, such as
alveolar macrophages, cannot be excluded. This mechanism is
likely important in patients with allergic asthma as these usually
have high levels of allergen-specific IgE that may form IgE
immune complexes with the specific allergen in their lungs. Our
results also suggest that IgE immune complex-mediated enhance-
ment of lung MCp numbers is an additional target for treating
patients with anti-IgE (omalizumab).
Acknowledgments
We would like to thank Lars Berglund at Uppsala Clinical Research Center
for advice on statistical analysis. We are also grateful to Annika
Hermansson and Yue Cui for technical help.
Author Contributions
Conceived and designed the experiments: JH JSD. Performed the
experiments: JSD JH MAI. Analyzed the data: JSD MAI JH BH. Wrote
the paper: JH JSD BH.
References
1. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, et al. (2002)
Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 346:
1699–1705.
2. Yu M, Tsai M, Tam SY, Jones C, Zehnder J, et al. (2006) Mast cells can
promote the development of multiple features of chronic asthma in mice. J Clin
Invest 116: 1633–1641.
3. Hallgren J, Jones TG, Abonia JP, Xing W, Humbles A, et al. (2007) Pulmonary
CXCR2 regulates VCAM-1 and antigen-induced recruitment of mast cell
progenitors. Proc Natl Acad Sci U S A 104: 20478–20483.
4. Hallgren J, Gurish MF (2007) Pathways of murine mast cell development and
trafficking: tracking the roots and routes of the mast cell. Immunol Rev 217:
8–18.
5. Abonia JP, Hallgren J, Jones T, Shi T, Xu Y, et al. (2006) Alpha-4 integrins and
VCAM-1, but not MAdCAM-1, are essential for recruitment of mast cell
progenitors to the inflamed lung. Blood 108: 1588–1594.
6. Collington SJ, Hallgren J, Pease JE, Jones TG, Rollins BJ, et al. (2010) The role
of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo.
J Immunol 184: 6114–6123.
7. Jones TG, Hallgren J, Humbles A, Burwell T, Finkelman FD, et al. (2009)
Antigen-induced increases in pulmonary mast cell progenitor numbers depend
on IL-9 and CD1d-restricted NKT cells. J Immunol 183: 5251–5260.
8. Holgate S, Smith N, Massanari M, Jimenez P (2009) Effects of omalizumab on
markers of inflammation in patients with allergic asthma. Allergy 64:
1728–1736.
9. van Herwerden L, Harrap SB, Wong ZY, Abramson MJ, Kutin JJ, et al. (1995)
Linkage of high-affinity IgE receptor gene with bronchial hyperreactivity, even
in absence of atopy. Lancet 346: 1262–1265.
10. Sears MR, Burrows B, Flannery EM, Herbison GP, Hewitt CJ, et al. (1991)
Relation between airway responsiveness and serum IgE in children with asthma
and in apparently normal children. N Engl J Med 325: 1067–1071.
11. Kawakami T, Galli SJ (2002) Regulation of mast-cell and basophil function and
survival by IgE. Nat Rev Immunol 2: 773–786.
12. Takizawa F, Adamczewski M, Kinet JP (1992) Identification of the low affinity
receptor for immunoglobulin E on mouse mast cells and macrophages as Fc
gamma RII and Fc gamma RIII. J Exp Med 176: 469–475.
13. Hirano M, Davis RS, Fine WD, Nakamura S, Shimizu K, et al. (2007) IgEb
immune complexes activate macrophages through FcgammaRIV binding. Nat
Immunol 8: 762–771.
14. Mancardi DA, Iannascoli B, Hoos S, England P, Daeron M, et al. (2008)
FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI
in humans and promotes IgE-induced lung inflammation. J Clin Invest 118:
3738–3750.
15. Getahun A, Heyman B (2006) How antibodies act as natural adjuvants.
Immunol Lett 104: 38–45.
16. Heyman B (2002) IgE-mediated enhancement of antibody responses: the
beneficial function of IgE? Allergy 57: 577–585.
17. Fujiwara H, Kikutani H, Suematsu S, Naka T, Yoshida K, et al. (1994) The
absence of IgE antibody-mediated augmentation of immune responses in CD23-
deficient mice. Proc Natl Acad Sci U S A 91: 6835–6839.
18. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV (1994) FcR gamma chain
deletion results in pleiotrophic effector cell defects. Cell 76: 519–529.
19. Good A, Wofsy L, Henry C, Kimura J (1980) Preparations of hapten modified
protein antigens; BB. Mishell aSMS, ed. San FranciscoCA: W.H. Freeman and
Co.
20. Rudolph AK, Burrows PD, Wabl MR (1981) Thirteen hybridomas secreting
hapten-specific immunoglobulin E from mice with Iga or Igb heavy chain
haplotype. Eur J Immunol 11: 527–529.
21. Getahun A, Hjelm F, Heyman B (2005) IgE enhances antibody and T cell
responses in vivo via CD23+ B cells. J Immunol 175: 1473–1482.
22. Karasuyama H (1988) [Establishment of mouse cell lines which constitutively
secrete large quantities of interleukin 2, 3, 4 or 5, using high-copy cDNA
expression vectors]. Tanpakushitsu Kakusan Koso 33: 2527–2532.
23. Gurish MF, Tao H, Abonia JP, Arya A, Friend DS, et al. (2001) Intestinal mast
cell progenitors require CD49dbeta7 (alpha4beta7 integrin) for tissue-specific
homing. J Exp Med 194: 1243–1252.
24. Crapper RM, Schrader JW (1983) Frequency of mast cell precursors in normal
tissues determined by an in vitro assay: antigen induces parallel increases in the
frequency of P cell precursors and mast cells. J Immunol 131: 923–928.
25. Abonia JP, Austen KF, Rollins BJ, Joshi SK, Flavell RA, et al. (2005)
Constitutive homing of mast cell progenitors to the intestine depends on
autologous expression of the chemokine receptor CXCR2. Blood 105:
4308–4313.
26. Zuberi RI, Apgar JR, Chen SS, Liu FT (2000) Role for IgE in airway secretions:
IgE immune complexes are more potent inducers than antigen alone of airway
inflammation in a murine model. J Immunol 164: 2667–2673.
27. Chvatchko Y, Kosco-Vilbois MH, Herren S, Lefort J, Bonnefoy JY (1996)
Germinal center formation and local immunoglobulin E (IgE) production in the
lung after an airway antigenic challenge. J Exp Med 184: 2353–2360.
28. Mathias CB, Freyschmidt EJ, Caplan B, Jones T, Poddighe D, et al. (2009) IgE
influences the number and function of mature mast cells, but not progenitor
recruitment in allergic pulmonary inflammation. J Immunol 182: 2416–2424.
29. Gould HJ, Sutton BJ (2008) IgE in allergy and asthma today. Nat Rev Immunol
8: 205–217.
30. Hjelm F, Karlsson MC, Heyman B (2008) A novel B cell-mediated transport of
IgE-immune complexes to the follicle of the spleen. J Immunol 180: 6604–6610.
31. Teuscher C, Yanagihara D, Brennan PJ, Koster FT, Tung KS (1985) Antibody
response to phenolic glycolipid I in inbred mice immunized with Mycobacterium
leprae. Infect Immun 48: 474–479.
32. Sterk AR, Ishizaka T (1982) Binding properties of IgE receptors on normal
mouse mast cells. J Immunol 128: 838–843.
IgE-IC Increase Lung Mast Cell Progenitors
PLoS ONE | www.plosone.org 8 May 2011 | Volume 6 | Issue 5 | e20261